Cobalt Healthcare Cheltenham & Gloucestershire Skip to primary naivgation Skip to content Donate

Lung cancer screening: The slow return of mobile units

Cobalt News, Imaging, Mobile

3rd December 2020

The coronavirus pandemic has had a severe impact on healthcare services but one area where that has been felt particularly deeply is with lung cancer screening. With sessions cancelled, treatment delays and social-distancing and safety requirements, many patients have been affected.
Report: Mark Nicholls

However, as services begin to pick up again and lung cancer screening returns, three experts closely associated with the field offered their insights into what the future may hold under the ‘new normal’ for screening in the UK.

Professor Richard Booton, Consultant Respiratory Physician in the North West Lung Centre and Clinical Director for Lung Cancer and Thoracic Surgery at Wythenshawe Hospital in Manchester

Ahead of the British Institute of Radiology’s lung cancer imaging event, the three experts participated in a pre-session presentation and live Q&A entitled ‘Relaunching a lung cancer screening service in the new normal’. Professor Richard Booton, Consultant Respiratory Physician in the North West Lung Centre and Clinical Director for Lung Cancer and Thoracic Surgery at Wythenshawe Hospital in Manchester, offered a clinician’s insight into how lung screening has changed post-Covid. There were challenges in relaunching services within a community, he said, but, with reassurance to participants, the uptake remained high, though he acknowledged that the Covid-19 has impacted beyond community settings and into hospitals.

‘In the diagnostic arena, the impact of Covid reduces our capacity, not least in CT scanning, lung function, bronchoscopy, CT-guided lung biopsies and PET scanning, and this is all a consequence of social distancing and requirement for Covid testing,’ he added. ‘In treatment terms having patients isolate, added time for donning PPE, reduced operating time, theatre access and anaesthetic availability, all have an impact. This creates an enormous propensity for delay, which was common pre-Covid and is going to continue to be common, if not exacerbated.’

Lack of screening infrastructure

He pointed to a lack of screening infrastructure, the inability to get people quickly through the MDT (multi-disciplinary team) process and into treatment, and the UK’s ‘woeful’ lack of CT capacity, as ongoing issues. Compliance to the 62-day target from urgent general practitioner (GP) referral to treatment continues to fall and he suspected that would get worse in the months ahead.

Booton said the pandemic had provided some ‘illumination’ on the difficult cancer screening landscape and highlighted the need to invest in workforce, diagnostics, to roll out faster pathways, and see more joined up collaboration in the UK’s cancer alliances, as well as some centralisation in delivering complex pathways. ‘Delay in lung cancer care,’ he said, in conclusion, ‘is not new but there is no doubt Covid will further compromise and slow care as capacity becomes a real problem. We need to fight for that capacity now as we enter the recovery phase – both within our hospitals and across our cancer alliances.’

Peter Sharpe, CEO of Cobalt

The session also heard from Peter Sharpe, CEO of Cobalt Health – a charitable organisation which offers mobile lung cancer screening services – on the challenges of relaunching the service post-lockdown. In Manchester, during the year prior to lockdown in March, the organisation’s mobile scanning units conducted 8,972 lung health checks (LHCs), including 4,555 low dose CT scans, found 88 lung cancers. But in March, the programmes were paused and the charity’s scanners went to support NHS England (NHSE) Covid-19 response by providing urgent oncology scans for hospitals across England.

Now, with the relaunch of the programme, the challenges are in maintaining social distancing, use of PPE, cleaning the equipment and also returning to previous locations, which were often in supermarket car parks, combined with a continuing high demand for CT across England.

Mobile scans on a supermarket car park

Some of the scan preparation processes, such as risk assessments, are being carried out by phone or video call and patients are invited to attend for mobile scans alone and scan-ready in their dress. Spirometry and blood pressure checks remain suspended. The scanners have enough space within to maintain social distancing, but supermarkets have been reluctant to allow the units back on their sites, though a unit has been situated at Manchester City’s Etihad football stadium. Scheduled attendance has been lower to facilitate social distancing and there have been some same-day cancellations by patients who are nervous about venturing out as many have been shielding. But those willing to attend the mobile unit have been well-prepared and often feel more comfortable in a mobile screening setting than attending hospital. ‘It is early days, but we still believe lung health checks will be an effective programme for lung cancer screening,’ said Sharpe.

AI in lung cancer screening

Hasan Jouni, Business Development Manager, Siemens Healthineers, addressed the session about the role Artificial Intelligence has to play with some of the challenges faced in lung cancer screening, detailing how the AI-Rad Companion product chest CT and chest X-ray modules can help. He said they could be utilised to address backlogs in scan reporting and, while not providing a substitute for the radiologist, could help with routine, labour intensive, aspects of the workload by making in-roads into delays in reporting and improve turnaround time.

Article source: https://healthcare-in-europe.com/en/news/lung-cancer-screening-the-slow-return-of-mobile-units.html

 

Next
Share Share

Get involved

There are so many ways to get involved and raise money for Cobalt.

Get involved

Donate

Help raise money with fundraising events, collections, one of donations, and more.

Find out more

Contact us

For more information about raising money for Cobalt please email our fundraising team on fundraising@cobalthealth.co.uk

Contact the fundraising team
  • Previous
  • Next
  • Patients
    • Patient Info
    • Cobalt Imaging Centre Tour
    • Scan Prices
    • Rapid Access Clinics
    • Your Results
    • Diagnostic Scans
    • Useful Contacts for Patients
    • Clinical Quality Assurance
    • Frequently Asked Questions
  • Medical Professionals
    • Referring Your Patients
    • GP MRI & CT Referrals
    • Diagnostic Scans
    • Useful contacts for medical professionals
    • Education
    • Research
    • MRI Training Programme
  • Cobalt
    • Our management team
    • Our Trustees
    • Contact
    • Latest News
    • About Us
    • Our History
    • Downloads
    • Careers
    • Testimonials
  • Support Us
    • The Big Give – You helped raise over £35,000!
    • Get Up Get Going
    • Cobalt Greetings Cards Online
    • Cobalt’s Kitchen Table
    • Making a Donation
    • Latest News
    • Make a Will Month
    • Our appeals and see how your support helps
    • Volunteering
    • Sign up
    • Fundraising FAQ
    • Thank you
Our work relies on your donations so get involved and help us make a difference.
Donate

Address

Cobalt
Linton House Clinic
Thirlestaine Road
Cheltenham
Gloucestershire
GL53 7AS

Contact

Phone: 01242 535900
Email: enquiries@cobalthealth.co.uk

Address

Cobalt
Linton House Clinic
Thirlestaine Road
Cheltenham
Gloucestershire
GL53 7AS

Contact

Phone: 01242 535900
Fax: 01242 535919
Email: enquiries@cobalthealth.co.uk

MRI Phone: 0800 138 7201
PET/CT Phone: 0800 138 7202

Support Us

Fundraising: 01242 535922
Email: fundraising@cobalthealth.co.uk

Cobalt Health, a Registered Charity No. 1090790
Company limited by guarantee, registered in England no. 4366596
Registered office: Linton House Clinic, Thirlestaine Road, Cheltenham, Glos GL53 7AS

  • Terms & Conditions
  • Privacy Policy
  • Cookies
We use cookies to give you the best experience possible. Click accept to continue exploring or find out more in our cookie policy. Read More Accept Reject
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.